CompletedNot Applicable

Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community

Kyrgyzstan, Moldova, Ukraine835 participantsStarted 2017-01-01

Plain-language summary

The purpose of this study is to evaluate the efficacy a Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for linking opioid dependent individuals currently incarcerated or in probation in Moldova, Kyrgyzstan, and Ukraine to opioid substitution therapy in the community after release or during their probation period.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years of age or older
✓. Within 180 days of release or possible release (eligible for parole) to the community, but greater than 7 days to release to the community OR currently in probation.
✓. FOR THOSE IN PRISON: Relocating to a location within 30 km (approximately 60-minute commute) of the referred Narcology center. Each participant will be asked the address he/she is planning to reside under that will be immediately checked on the map to determine the travel time. A participant then will be asked if he/she would be willing to travel the distance to a particular OAT site. If a person does not meet this inclusion criterion, he/she will be referred to a local harm reduction center.
✓. Meets ICD-10 screening criteria for pre-incarceration opioid dependence
✓. Living within 30 km of an OAT delivery site
✓. Not having received OAT in the last 15 days.
✓. Positive for OUD

Exclusion criteria

✕. Pregnant or may become pregnant
✕. FOR THOSE IN PRISON: Will be released from prison in 7 days or less.

What they're measuring

Enrollment on OAT

Timeframe: 12 months

Trial details

NCT IDNCT04947475

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-30

View on ClinicalTrials.gov More Opioid-use Disorder trials